Wire · opportunities
What Merck and SCRI's Community Network Deal Actually Means for Site Operations
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 24 August 2026 · Fusion42 review
Merck and SCRI's collaboration aims to expand oncology clinical trial access at over 200 community-based sites across the U.S. through a standardized network model, but operational challenges at individual sites remain significant barriers to rapid trial activation.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
The move to streamline trial contracting upstream exposes the bottleneck in site readiness that you must fix to activate patients fast. Your operations need early focus on local pharmacy, coordinator training, and feasibility work or your signed contracts mean little.
◆ Coverage
1 source · 24 Aug 2026
◆ Related on Wire
◆ Topics